Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Blood Group Typing Market, By Product
7.1. Blood Group Typing Market, By Product, 2021-2028
7.1.1. Consumables
7.1.1.1. Market Revenue and Forecast (2016-2028)
7.1.2. Instruments
7.1.2.1. Market Revenue and Forecast (2016-2028)
7.1.3. Services
7.1.3.1. Market Revenue and Forecast (2016-2028)
Chapter 8. Global Blood Group Typing Market, By Technique
8.1. Blood Group Typing Market, By Technique, 2021-2028
8.1.1. PCR-based and Microarray Techniques
8.1.1.1. Market Revenue and Forecast (2016-2028)
8.1.2. Assay-based Techniques
8.1.2.1. Market Revenue and Forecast (2016-2028)
8.1.3. Massively Parallel Sequencing Techniques
8.1.3.1. Market Revenue and Forecast (2016-2028)
8.1.4. Other Techniques
8.1.4.1. Market Revenue and Forecast (2016-2028)
Chapter 9. Global Blood Group Typing Market, By Test Type
9.1. Blood Group Typing Market, By Test Type, 2021-2028
9.1.1. Antibody Screening
9.1.1.1. Market Revenue and Forecast (2016-2028)
9.1.2. HLA Typing
9.1.2.1. Market Revenue and Forecast (2016-2028)
9.1.3. Cross-matching Tests
9.1.3.1. Market Revenue and Forecast (2016-2028)
9.1.4. ABO Blood Tests
9.1.4.1. Market Revenue and Forecast (2016-2028)
9.1.5. Antigen Typing
9.1.5.1. Market Revenue and Forecast (2016-2028)
Chapter 10. Global Blood Group Typing Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, By Product (2016-2028)
10.1.2. Market Revenue and Forecast, By Technique (2016-2028)
10.1.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, By Product (2016-2028)
10.1.4.2. Market Revenue and Forecast, By Technique (2016-2028)
10.1.4.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, By Product (2016-2028)
10.1.5.2. Market Revenue and Forecast, By Technique (2016-2028)
10.1.5.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.2. Europe
10.2.1. Market Revenue and Forecast, By Product (2016-2028)
10.2.2. Market Revenue and Forecast, By Technique (2016-2028)
10.2.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, By Product (2016-2028)
10.2.4.2. Market Revenue and Forecast, By Technique (2016-2028)
10.2.4.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, By Product (2016-2028)
10.2.5.2. Market Revenue and Forecast, By Technique (2016-2028)
10.2.5.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, By Product (2016-2028)
10.2.6.2. Market Revenue and Forecast, By Technique (2016-2028)
10.2.6.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, By Product (2016-2028)
10.2.7.2. Market Revenue and Forecast, By Technique (2016-2028)
10.2.7.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.3. APAC
10.3.1. Market Revenue and Forecast, By Product (2016-2028)
10.3.2. Market Revenue and Forecast, By Technique (2016-2028)
10.3.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, By Product (2016-2028)
10.3.4.2. Market Revenue and Forecast, By Technique (2016-2028)
10.3.4.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, By Product (2016-2028)
10.3.5.2. Market Revenue and Forecast, By Technique (2016-2028)
10.3.5.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, By Product (2016-2028)
10.3.6.2. Market Revenue and Forecast, By Technique (2016-2028)
10.3.6.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, By Product (2016-2028)
10.3.7.2. Market Revenue and Forecast, By Technique (2016-2028)
10.3.7.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.4. MEA
10.4.1. Market Revenue and Forecast, By Product (2016-2028)
10.4.2. Market Revenue and Forecast, By Technique (2016-2028)
10.4.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, By Product (2016-2028)
10.4.4.2. Market Revenue and Forecast, By Technique (2016-2028)
10.4.4.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, By Product (2016-2028)
10.4.5.2. Market Revenue and Forecast, By Technique (2016-2028)
10.4.5.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, By Product (2016-2028)
10.4.6.2. Market Revenue and Forecast, By Technique (2016-2028)
10.4.6.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, By Product (2016-2028)
10.4.7.2. Market Revenue and Forecast, By Technique (2016-2028)
10.4.7.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.5. Latin America
10.5.1. Market Revenue and Forecast, By Product (2016-2028)
10.5.2. Market Revenue and Forecast, By Technique (2016-2028)
10.5.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, By Product (2016-2028)
10.5.4.2. Market Revenue and Forecast, By Technique (2016-2028)
10.5.4.3. Market Revenue and Forecast, By Test Type (2016-2028)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, By Product (2016-2028)
10.5.5.2. Market Revenue and Forecast, By Technique (2016-2028)
10.5.5.3. Market Revenue and Forecast, By Test Type (2016-2028)
Chapter 11. Company Profiles
11.1. Grifols, S.A.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Merck KGaA
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Bio-Rad Laboratories, Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Immucor, Inc.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Novacyt Group
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Danaher Corporation
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Agena Bioscience, Inc.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Ortho Clinical Diagnostics
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Quotient, Ltd.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
Glossary of Terms